These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9221984)

  • 1. Neuroleptic malignant syndrome-like condition in multiple system atrophy.
    Konagaya M; Goto Y; Matsuoka Y; Konishi T; Konagaya Y
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):120-1. PubMed ID: 9221984
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome without neuroleptics.
    Ong KC; Chew EL; Ong YY
    Singapore Med J; 2001 Feb; 42(2):85-8. PubMed ID: 11358199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome in striatonigral degeneration.
    Itoh M; Nakano E; Ieshima A; Takeshita K
    Pediatr Neurol; 1995 Oct; 13(3):255-6. PubMed ID: 8554665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroleptic malignant syndrome after withdrawal of levopoda].
    Cedeno-Veloz B; Areosa Sastre A
    Rev Esp Geriatr Gerontol; 2018; 53(5):299-300. PubMed ID: 29628214
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome in parkinsonian patients: risk factors.
    Kuno S; Mizuta E; Yamasaki S
    Eur Neurol; 1997; 38 Suppl 2():56-9. PubMed ID: 9387804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preface: Malignant syndrome in Parkinson's disease.
    Narabayashi H; Mizuno Y
    Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S1. PubMed ID: 12735908
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome in advanced Parkinson's disease.
    Gordon PH; Frucht SJ
    Mov Disord; 2001 Sep; 16(5):960-2. PubMed ID: 11746631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome without neuroleptics.
    Parsa MA; Rohr T; Ramirez LF; Meltzer HY
    J Clin Psychopharmacol; 1990 Dec; 10(6):437-8. PubMed ID: 2286714
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of malignant syndrome associated with a parkinsonism patient.
    Sanga M; Nomura S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Apr; 23(2):91-5. PubMed ID: 12762221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Case of Total Parenteral Nutrition Precipitated Neuroleptic Malignant-Like Syndrome in Advanced Stage Parkinson Disease.
    Li W; Saweris M; Madhira B
    Am J Ther; 2018; 25(5):e606-e607. PubMed ID: 28731860
    [No Abstract]   [Full Text] [Related]  

  • 11. Intestinal pseudo-obstruction and neuroleptic malignant syndrome in a chronically constipated parkinsonian patient.
    Shimada J; Sakakibara R; Uchiyama T; Liu Z; Yamamoto T; Ito T; Mori M; Asahina M; Hattori T
    Eur J Neurol; 2006 Mar; 13(3):306-7. PubMed ID: 16618352
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroleptic malignant-like syndrome in an elderly patient caused by abrupt withdrawal of tolcapone, a-catechol-o-methyl transferase inhibitor.
    Iwuagwu CU; Riley D; Bonoma RA
    Am J Med; 2000 Apr; 108(6):517-8. PubMed ID: 10866587
    [No Abstract]   [Full Text] [Related]  

  • 13. Fulminant neuroleptic malignant syndrome after perioperative withdrawal of antiParkinsonian medication.
    Stotz M; Thümmler D; Schürch M; Renggli JC; Urwyler A; Pargger H
    Br J Anaesth; 2004 Dec; 93(6):868-71. PubMed ID: 15377584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome in striatonigral degeneration.
    Gibb WR
    Br J Psychiatry; 1988 Aug; 153():254-5. PubMed ID: 3255444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic malignant-like syndrome: case report.
    Tibbels CK; Seegers S
    Tex Med; 1988 May; 84(5):40-3. PubMed ID: 3406898
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome postoperative onset due to levodopa withdrawal.
    Young CC; Kaufman BS
    J Clin Anesth; 1995 Dec; 7(8):652-6. PubMed ID: 8747565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant like syndrome in two patients on cholinesterase inhibitors.
    Grace JB; Thompson P
    Int J Geriatr Psychiatry; 2006 Feb; 21(2):193-4. PubMed ID: 16440373
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
    Ward C
    J Neurosci Nurs; 2005 Jun; 37(3):160-2. PubMed ID: 16001822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal-induced neuroleptic malignant syndrome.
    Bower DJ; Chalasani P; Ammons JC
    Am J Psychiatry; 1994 Mar; 151(3):451-2. PubMed ID: 8109662
    [No Abstract]   [Full Text] [Related]  

  • 20. Urodynamic and neurophysiological evaluation in Parkinson's disease and multiple system atrophy.
    Stocchi F; Carbone A; Inghilleri M; Monge A; Ruggieri S; Berardelli A; Manfredi M
    J Neurol Neurosurg Psychiatry; 1997 May; 62(5):507-11. PubMed ID: 9153611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.